Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lanthanides as anticancer agents.

Irena Kostova1

  • 1Department of Chemistry, Faculty of Pharmacy, Medical University, 2 Dunav St., Sofia 1000, Bulgaria. irenakostova@yahoo.com

Current Medicinal Chemistry. Anti-Cancer Agents
|November 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterometallic Multinuclear Ruthenium Complexes as Cytotoxic Agents.

Biomedicines·2026
Same author

Parabiotics as Next-Generation Microbiome Therapeutics: Insights into Mechanisms, Evidence, and Therapeutic Potential.

Current microbiology·2026
Same author

Retraction Notice: Titanium and Vanadium Complexes as Anticancer Agents.

Anti-cancer agents in medicinal chemistry·2026
Same author

Recent Advances in Anticancer Research of Osmium and Rhodium Complexes.

Medicinal chemistry (Shariqah (United Arab Emirates))·2025
Same author

Homometallic Polynuclear Rhodium Complexes in Anticancer Drug Development.

Mini reviews in medicinal chemistry·2025
Same author

Cytotoxic Organometallic Iridium(III) Complexes.

Molecules (Basel, Switzerland)·2025
Same journal

Selenium derivatives as cancer preventive agents.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Lycopene: a review of its potential as an anticancer agent.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Sulfo-quinovosyl-acyl-glycerol (SQAG), a eukaryotic DNA polymerase inhibitor and anti-cancer agent.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Current drug therapy for prostate cancer: an overview.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy.

Current medicinal chemistry. Anti-cancer agents·2005
Same journal

An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein-inhibitor complexes.

Current medicinal chemistry. Anti-cancer agents·2005
See all related articles

Lanthanide coordination complexes show promise as novel anticancer agents, offering broader activity and overcoming resistance compared to platinum drugs. These metal-based compounds are also valuable for radioimmunotherapy and photodynamic therapy.

Area of Science:

  • Inorganic chemistry
  • Medicinal chemistry
  • Biocoordination chemistry

Background:

  • Metal-based drugs, like cisplatin, are vital in cancer treatment but face limitations due to side effects and resistance.
  • Biocoordination chemistry advances are key to designing safer, more effective metal compounds with understood mechanisms.

Purpose of the Study:

  • To review recent advances in lanthanide anticancer agents, focusing on coordination complexes.
  • To compare lanthanide complexes with traditional platinum-based anticancer drugs.
  • To highlight lanthanides' potential in radioimmunotherapy and photodynamic therapy.

Main Methods:

  • Review of recent literature on lanthanide coordination complexes for anticancer applications.
  • Comparative analysis of lanthanide complexes against platinum-based drugs regarding efficacy and resistance mechanisms.

Related Experiment Videos

  • Exploration of lanthanides' roles in targeted drug delivery and novel therapeutic modalities.

    • Main Results:

    • Lanthanide coordination complexes demonstrate potential for a broader spectrum of antitumor activity.
    • These complexes offer alternative mechanisms of action to overcome drug resistance observed with platinum agents.
    • Lanthanides possess therapeutic radioisotopes valuable for targeted cancer therapies.

    Conclusions:

    • Lanthanide coordination complexes represent a promising new frontier in cancer therapy, potentially overcoming limitations of current treatments.
    • Further research into lanthanide complexes could lead to improved drug design, reduced toxicity, and enhanced therapeutic outcomes.
    • The unique properties of lanthanides position them as versatile agents for various oncological applications, including targeted therapies.